A Hitchhiker's guide to the blood-brain barrier: in trans delivery of a therapeutic enzyme
- PMID: 24584077
- PMCID: PMC3944337
- DOI: 10.1038/mt.2014.12
A Hitchhiker's guide to the blood-brain barrier: in trans delivery of a therapeutic enzyme
Comment on
-
Effective intravenous therapy for neurodegenerative disease with a therapeutic enzyme and a peptide that mediates delivery to the brain.Mol Ther. 2014 Mar;22(3):547-553. doi: 10.1038/mt.2013.267. Epub 2013 Dec 26. Mol Ther. 2014. PMID: 24394185 Free PMC article.
References
-
- Desnick RJ, Schuchman EH. Enzyme replacement therapy for lysosomal storage diseases: lessons from 20 years of experience and remaining challenges. Annu Rev Genomics Hum Genet. 2012;13:307–335. - PubMed
-
- Neufeld EF, Fratantoni JC. Inborn errors of mucopolysaccharide metabolism. Science. 1970;169:141–146. - PubMed
-
- Achord DT, Brot CE, Bell E, Sly WS. Human beta-glucuronidase: in vivo clearance and in vitro uptake by a glycoprotein recognition system on reticuloendothelial cells. Cell. 1978;15:269–278. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
